Xiaofei Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Hepatology 12
- Liver Disease and Transplantation 5
- Hepatitis C virus research 5
- Epidemiology 19
- Liver Disease Diagnosis and Treatment 16
- Co-authors
- Jie Ding (1 shared paper)Kaichun Wu (1 shared paper)William G Hartley (3 shared papers)Xiangfeng Kong (3 shared papers)Shengguo Xue (3 shared papers)Chuan Wu (2 shared papers)Yuzhen Ye (2 shared papers)Meng Li (1 shared paper)
- Journals
- Pacing and Clinical Electrophysiology (3 papers)Liver International (3 papers)Digestive and Liver Disease (3 papers)Heart Rhythm (2 papers)Food & Function (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaofei Li
57 papers receiving 1.8k citations
Xiaofei Li's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 324
- Pulmonary and Respiratory Medicine 364
- Building and Construction 148
- Inorganic Chemistry 141
- Environmental Chemistry 93
Countries citing papers authored by Xiaofei Li
This map shows the geographic impact of Xiaofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Li more than expected).
Fields of papers citing papers by Xiaofei Li
This network shows the impact of papers produced by Xiaofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Li. The network helps show where Xiaofei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study Hit paper breakdown → | 2017 | 424 |
| 2 | 2009 | 283 | |
| 3 | 2016 | 157 | |
| 4 | 2019 | 154 | |
| 5 | 2020 | 103 | |
| 6 | 2012 | 90 | |
| 7 | 2015 | 72 | |
| 8 | 2010 | 64 | |
| 9 | 2014 | 55 | |
| 10 | 2018 | 45 | |
| 11 | 2024 | 41 | |
| 12 | 2016 | 39 | |
| 13 | 2012 | 28 | |
| 14 | 2018 | 25 | |
| 15 | 2016 | 23 | |
| 16 | 2015 | 21 | |
| 17 | 2018 | 21 | |
| 18 | 2021 | 20 | |
| 19 | 2021 | 19 | |
| 20 | 2017 | 16 |
About Xiaofei Li
Xiaofei Li is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Cardiac pacing and defibrillation studies (7 papers), Liver Disease and Transplantation (5 papers), Hepatitis C virus research (5 papers), Recycling and utilization of industrial and municipal waste in materials production (3 papers), Tea Polyphenols and Effects (3 papers), Nutrition and Health in Aging (3 papers) and Radioactive element chemistry and processing (3 papers). The work is most often cited by research in Cancer Research (324 citations), Pulmonary and Respiratory Medicine (364 citations), Building and Construction (148 citations), Inorganic Chemistry (141 citations) and Environmental Chemistry (93 citations). Xiaofei Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jie Ding, Kaichun Wu, William G Hartley, Xiangfeng Kong, Shengguo Xue, Chuan Wu, Yuzhen Ye, Meng Li, Chengrong R. Chen and Yiwei Li. Their work appears in journals such as Pacing and Clinical Electrophysiology, Liver International, Digestive and Liver Disease, Heart Rhythm and Food & Function.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.